Nanovector Nordic wallpaper Nordic Nanovector NANOV today provides an update on PARADIGME its Phase 2b trial of Betalutin 177 Lu lilotomab satetraxetan in 3 rd-line. Nordic Na… Wednesday, July 6, 2022 Edit